aldesleukin
aldesleukin is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including PROLEUKIN. Available dosage form: injection, powder, lyophilized, for solution.
Drug details
- Generic Name
- aldesleukin
- Brand Names
- PROLEUKIN
- Application Number
- BLA103293
- Sponsor
- Iovance Biotherapeutics, Inc
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- ALDESLEUKIN
Indications and Usage
1 INDICATIONS AND USAGE Proleukin is a lymphocyte growth factor indicated for: The treatment of adults with metastatic renal cell carcinoma. ( 1.1 ) The treatment of adults with metastatic melanoma. ( 1.2 ) 1.1 Metastatic Renal Cell Carcinoma Proleukin is indicated for the treatment of adults with metastatic renal cell carcinoma (RCC). 1.2 Metastatic Melanoma Proleukin is indicated for the treatment of adults with metastatic melanoma.